Publications by authors named "Brian L Heiss"

5Publications

COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.

Authors:
Garth W Strohbehn Brian L Heiss Sherin J Rouhani Jonathan A Trujillo Jovian Yu Alec J Kacew Emily F Higgs Jeffrey C Bloodworth Alexandra Cabanov Rachel C Wright Adriana K Koziol Alexandra Weiss Keith Danahey Theodore G Karrison Cuoghi C Edens Iazsmin Bauer Ventura Natasha N Pettit Bhakti K Patel Jennifer Pisano Mary E Strek Thomas F Gajewski Mark J Ratain Pankti D Reid

Clin Pharmacol Ther 2020 Nov 18. Epub 2020 Nov 18.

Department of Medicine, Section of Rheumatology, The University of Chicago, Chicago, Illinois, USA.

View Article and Find Full Text PDF
November 2020

COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19.

Authors:
Garth W Strohbehn Brian L Heiss Sherin J Rouhani Jonathan A Trujillo Jovian Yu Alec J Kacew Emily F Higgs Jeffrey C Bloodworth Alexandra Cabanov Rachel C Wright Adriana Koziol Alexandra Weiss Keith Danahey Theodore G Karrison Cuoghi C Edens Iazsmin Bauer Ventura Natasha N Pettit Bhakti Patel Jennifer Pisano Mary E Strek Thomas F Gajewski Mark J Ratain Pankti D Reid

medRxiv 2020 Jul 26. Epub 2020 Jul 26.

View Article and Find Full Text PDF
July 2020

Trastuzumab-induced cardiomyopathy: incidence and associated risk factors in an inner-city population.

Authors:
Kaitlin B Baron Jennifer R Brown Brian L Heiss Joanne Marshall Nancy Tait Katherine H R Tkaczuk Stephen S Gottlieb

J Card Fail 2014 Aug 4;20(8):555-9. Epub 2014 Jun 4.

University of Maryland School of Medicine, Divisions of Cardiology and Hematology/Oncology, Department of Medicine, Baltimore, MD. Electronic address:

View Article and Find Full Text PDF
August 2014

MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype.

Authors:
Brian L Heiss Olga A Maximova Dzung C Thach James M Speicher Alexander G Pletnev

J Virol 2012 May 14;86(10):5647-59. Epub 2012 Mar 14.

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

View Article and Find Full Text PDF
May 2012

Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.

Authors:
Brian L Heiss Olga A Maximova Alexander G Pletnev

J Virol 2011 Feb 1;85(4):1464-72. Epub 2010 Dec 1.

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article and Find Full Text PDF
February 2011